New Zealand markets open in 2 hours 22 minutes

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
90.99-1.86 (-2.00%)
At close: 04:00PM EDT
90.99 0.00 (0.00%)
After hours: 08:00PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
1,413,800
1,402,400
1,521,900
1,503,100
823,400
-
Depreciation & amortisation
148,200
144,900
139,600
134,800
107,200
-
Deferred income taxes
-256,100
-272,100
-254,500
-41,400
-49,400
-
Stock-based compensation
145,100
139,400
126,800
109,300
92,600
-
Change in working capital
-928,700
-526,300
-421,400
145,300
42,200
-
Inventory
-325,700
-289,000
-213,400
19,000
-120,600
-
Accounts payable
102,100
146,000
-21,400
195,200
-84,500
-
Other working capital
251,200
629,500
953,400
1,402,300
647,000
-
Other non-cash items
9,700
10,400
-800
-86,200
59,500
-
Net cash provided by operating activities
528,200
895,800
1,218,200
1,732,100
1,054,300
-
Cash flows from investing activities
Investments in property, plant and equipment
-277,000
-266,300
-264,800
-329,800
-407,300
-
Acquisitions, net
46,000
-95,200
0
0
0
-
Purchases of investments
-88,200
-105,500
-778,900
-1,892,400
-861,700
-
Sales/maturities of investments
618,500
715,800
1,359,100
529,200
777,000
-
Other investing activities
-62,900
-75,000
-63,100
-29,500
-39,100
-
Net cash used for investing activities
236,400
173,800
252,300
-1,722,500
-531,100
-
Cash flows from financing activities
Debt repayment
-
-300
-200
-7,000
-17,000
-
Common stock issued
-
-
-
-
-
160,500
Common stock repurchased
-630,500
-879,600
-1,727,100
-512,800
-625,400
-
Other financing activities
-2,000
-1,000
-3,600
-300
-1,200
-
Net cash used provided by (used for) financing activities
-442,700
-711,000
-1,584,500
-356,300
-486,900
-
Net change in cash
352,600
375,400
-94,800
-332,800
15,800
-
Cash at beginning of period
876,400
772,600
867,400
1,200,200
1,184,400
-
Cash at end of period
1,198,300
1,148,000
772,600
867,400
1,200,200
-
Free cash flow
Operating cash flow
528,200
895,800
1,218,200
1,732,100
1,054,300
-
Capital expenditure
-277,000
-266,300
-264,800
-329,800
-407,300
-
Free cash flow
251,200
629,500
953,400
1,402,300
647,000
-